Clinical Trials · NCT03996993
Defining Recurrent Disease With Axumin™
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Cancer Center of Irvine
- Enrollment
- 20
- Start date
- Jul 2019
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of baseline Axumin uptake